Document:

Exhibit 4.2

 

 

NEITHER THIS SECURITY NOR THE
SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON STOCK PURCHASE WARRANT

 

Esports Technologies, Inc.

 

	Warrant Shares: [●]	Issue Date: November 29, 2021

 

THIS COMMON STOCK PURCHASE WARRANT
(the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled,
upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Shareholder
Approval Date (as defined in the Purchase Agreement) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New
York City time) on the fifth anniversary of the Initial Exercise Date, (the “Termination Date”) but not thereafter,
to subscribe for and purchase from Esports Technologies, Inc., a Nevada corporation (the “Company”), up to [●]
of shares of Company common stock, par value $0.001 per share (the “Common Stock”) (the Common Stock issuable hereunder,
as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant
shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section 1.Definitions.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Subscription Agreement (the
“Purchase Agreement”), dated September 30, 2021, among the Company and the investors signatory thereto. In addition,
the following terms have the meanings indicated in this Section 1:

 

“Adjustment
Right” means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or
sale (or deemed issuance or sale in accordance with Section 3(b)) of Common Stock (other than rights of the type described in Section
3(d) hereof) that could result in a decrease in the net consideration received by the Company in connection with, or with respect to,
such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).

 

“Closing
Sale Price” means, for any security as of any date, the last closing trade price for such security on the Trading Market, as
reported by Bloomberg L.P., or, if the Trading Market begins to operate on an extended hours basis and does not designate the closing
trade price, then the last trade price of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg L.P., or, if the
Trading Market is not the principal securities exchange or trading market for such security, the last trade price of such security on
the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg L.P., or if the foregoing
does not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security
as reported by Bloomberg L.P., or, if no last trade price is reported for such security by Bloomberg L.P., the average of the ask prices
of any market makers for such security as reported on The Pink Open Market (or a similar organization or agency succeeding to its functions
of reporting prices). If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases,
the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.
All such determinations shall be appropriately adjusted for any share dividend, share split, share combination or other similar transaction
during such period.

 

 

 

 

    	 	1	 

     

    

 

“Convertible
Securities” means any shares or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any Common
Stock.

 

“Exempt
Issuance” means the issuance of (a) Common Stock or Options to employees, officers or directors of the Company pursuant to any
equity plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members
of a committee of non-employee directors established for such purpose for services rendered to the Company; (b) securities upon the exercise
or exchange of or conversion of any Securities issued in the Purchase Agreement and/or other securities exercisable or exchangeable for
or convertible into Common Stock issued and outstanding on the date of the Purchase Agreement, provided that such securities have not
been amended since the date of the Purchase Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with share splits or combinations) or to extend the term of such
securities, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors
of the Company, provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the current business of the Company at such
time and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction
in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities, and (d) securities issued in connection with any financings to be completed to fund the Acquisition.

 

“Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  the Common Stock is then listed or quoted on OTCQB or OTCQX, the
volume weighted average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the shares of Common Stock are not then listed or quoted for trading on a Trading Market, OTCQB or OTCQX and if prices for the
shares of Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date), or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the
Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.

 

Section 2.Exercise.

 

a)                  
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”,
and each such date, an “Exercise Date”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the
Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

 

 

    	 	2	 

     

    

 

b)                 
Exercise Price. The exercise price per Warrant Share under this Warrant shall be $30.00, subject to adjustment hereunder
(the “Exercise Price”).

 

c)                  
Cashless Exercise. If on the later of (i) the Shareholder Approval Date, or (ii) six months from the dates hereof, at the
time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available
for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means
of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient
obtained by dividing [(A-B) (X)] by (A), where:

 

	 	(A) = 	 as applicable: (i) the Closing Sale Price on the Trading Day immediately preceding the date of the applicable Notice of Exercise if
such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2)
both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours”
(as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of
the Holder, either (y) the Closing Sale Price on the Trading Day immediately preceding the date of the applicable Notice of Exercise
or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”)
as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular
trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the Closing Sale Price on the date
of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed
and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

 

	 	(B) = 	 the Exercise Price of this Warrant, as adjusted hereunder; and

 

	 	(X)= 	 the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.

 

d)                 
Mechanics of Exercise.

 

i.           
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. The Company agrees to
maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used
herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days,
on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.

 

 

 

 

    	 	3	 

     

    

 

ii.           
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new
Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.

 

iii.           
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv.           
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.

 

v.           
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this
Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the
Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.
The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Warrant Shares.

 

vi.           
Closing of Books. The Company will not close its shareholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

 

 

 

    	 	4	 

     

    

 

e)                  
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have
the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and
any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution
Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall
be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of the shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of
Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held
by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.

 

 

 

    	 	5	 

     

    

 

Section 3.Certain
Adjustments.

 

a)                  
Share Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or
otherwise makes a distribution or distributions on its Common Stock or any other equity or equity equivalent securities payable in Common
Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding Common Stock into a larger number of shares, (iii) combines (including by way of reverse share split) outstanding
Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any share capital of the
Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of
Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number
of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall
be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant
to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive
such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination
or re-classification.

 

b)                 
Adjustment Upon Issuance of Common Stock. If and whenever on or after the date hereof and prior to the one-year anniversary
of the date this Warrant is issued, the Company grants, issues or sells (or enters into any agreement to grant, issue or sell), or in
accordance with this Section 3(b) is deemed to have issued or sold, any shares of Common Stock (including the issuance or sale of Common
Stock owned or held by or for the account of the Company, but excluding any Exempt Issuances issued or sold or deemed to have been issued
or sold) for a consideration per share (the “New Issuance Price”) less than a price equal to the Exercise Price in
effect immediately prior to such issuance or sale or deemed issuance or sale (such Exercise Price then in effect is referred to herein
as the “Applicable Price”) (the foregoing a “Dilutive Issuance”), then immediately after such Dilutive
Issuance, the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price. For all purposes of the foregoing
(including, without limitation, determining the adjusted Exercise Price and the New Issuance Price under this Section 3(b)), the
following shall be applicable:

 

i.                       
Issuance of Options. If the Company in any manner grants, issues or sells any Options and the lowest price per share for
which Common Stock is issuable upon the exercise of such Options or upon conversion, exercise or exchange of any Convertible Securities
issuable upon exercise of such Options or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of
Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting, issuance or
sale of such Option for such price per share. Except as contemplated below, no further adjustment of the Exercise Price shall be made
upon the actual issuance of such Common Stock or of such Convertible Securities upon the exercise of such Options or upon the actual issuance
of such Common Stock upon conversion, exercise or exchange of such Convertible Securities.

 

ii.                       
Issuance of Convertible Securities. If the Company in any manner issues or sells any Convertible Securities and the lowest
price per share for which Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable Price,
then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance
or sale of such Convertible Securities for such price per share. Except as contemplated below, no further adjustment of the Exercise Price
shall be made upon the actual issuance of such Common Stock upon conversion, exercise or exchange of such Convertible Securities, and
if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Warrant
has been or is to be made pursuant to other provisions of this Section 3(b), except as contemplated below, no further adjustment of the
Exercise Price shall be made by reason of such issuance or sale.

 

 

 

 

    	 	6	 

     

    

 

iii.                       
Change in Option Price or Rate of Conversion. If the purchase or exercise price provided for in any Options, the additional
consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any
Convertible Securities are convertible into or exercisable or exchangeable for Common Stock increases or decreases at any time (other
than proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 3(a)), the
Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would have been in effect
at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration
or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section
3(b)(iii), if the terms of any Option or Convertible Security that was outstanding as of the Initial Exercise Date are increased or decreased
in the manner described in the immediately preceding sentence, then such Option or Convertible Security and the Common Stock deemed issuable
upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment
pursuant to this Section 3(b) shall be made if such adjustment would result in an increase of the Exercise Price then in effect.

 

iv.                       
Calculation of Consideration Received. If any Option and/or Convertible Security and/or Adjustment Right is issued
in connection with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Company,
the “Primary Security”, and such Option and/or Convertible Security and/or Adjustment Right, the “Secondary
Securities” and together with the Primary Security, each a “Unit”), together comprising one integrated transaction,
the aggregate consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lowest of (x) the
purchase price of such Unit, and (y) if such Primary Security is an Option and/or Convertible Security, the lowest price per share for
which one share of Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section
3(b)(i) or 3(b)(ii) above. If any shares of Common Stock, Options or Convertible Securities are issued or sold or deemed to have been
issued or sold for cash, the consideration received therefor will be deemed to be the net amount of consideration received by the Company
therefor. If any shares of Common Stock, Options or Convertible Securities are issued or sold for a consideration other than cash, the
amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration consists
of publicly traded securities, in which case the amount of consideration received by the Company for such securities will be the arithmetic
average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding the date of receipt. If any shares
of Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger
in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion
of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock, Options or Convertible
Securities (as the case may be). The fair value of any consideration other than cash or publicly traded securities will be determined
in good faith by the Company.

 

v.                       
Record Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A)
to receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe
for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the
issuance or sale of the Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other
distribution or the date of the granting of such right of subscription or purchase (as the case may be).

 

c)                  
Voluntary Adjustment by Company. The Company may at any time during the term of this Warrant, but after receipt of Shareholder
Approval and subject to the approval of the principal Trading Market, reduce the then current Exercise Price to any amount and for any
period of time deemed appropriate by the board of directors of the Company.

 

 

 

 

    	 	7	 

     

    

 

d)                 
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record
holders of any class of Common Stock (“Purchase Rights”), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

e)                  
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return
of capital or otherwise (including, without limitation, any distribution of cash, shares or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such
Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised
this Warrant.

 

 

 

 

    	 	8	 

     

    

 

f)                  
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company (or any Subsidiary), directly
or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii)
the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition
of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of shares of Common Stock are
permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50%
or more of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the
other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or
share purchase agreement or other business combination) (each a “Fundamental Transaction”), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of share capital of such Successor Entity (or its parent entity) equivalent to the Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such
Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such share capital (but taking into
account the relative value of the Common Stock pursuant to such Fundamental Transaction and the value of such share capital, such number
of shares in such share capital and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity
shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant
and the other Transaction Documents referring to the “Company” shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction
Documents with the same effect as if such Successor Entity had been named as the Company herein.

 

g)                 
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

 

 

 

    	 	9	 

     

    

 

h)                 
Notice to Holder.

 

i.           
Adjustment to Exercise Price. Whenever the Exercise Price or the number Warrant Shares subject to the Warrant is adjusted
pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise
Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
requiring such adjustment.

 

ii.           
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form)
on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any share capital
of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided pursuant to this Warrant constitutes, or contains, material, non-public information regarding
the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to Form 8-K report.
The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date
of the event triggering such notice except as may otherwise be expressly set forth herein.

 

i)                 
If Shareholder Approval (as defined in the Purchase Agreement) is not received by the Shareholder Meeting Deadline (as defined
in the Purchase Agreement), the number of Warrant Shares as of such date shall be equal to: (i) the Warrant Shares as of such date, multiplied
by (ii) 1.06667.

 

Section 4.Transfer
of Warrant.

 

a)                 
Transferability. Subject to compliance with any applicable securities laws, the conditions set forth in Section 4(d) hereof
and the provisions of Section 7 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if
properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant
issued.

 

 

 

 

    	 	10	 

     

    

 

b)                 
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)                  
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.

 

d)                 
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act
and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current
public information requirements pursuant to Rule 144.

 

e)                  
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.

 

Section 6.Miscellaneous.

 

a)                  
Currency. Unless otherwise indicated, all dollar amounts referred to in this Warrant are in United States Dollars (“U.S.
Dollars”). All amounts owing under this Warrant shall be paid in U.S. Dollars. All amounts denominated in other currencies shall
be converted in the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. “Exchange
Rate” means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Warrant, the U.S. Dollar
exchange rate as published in the Wall Street Journal (New York edition) on the relevant date of calculation.

 

b)                 
No Rights as Shareholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other
rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in
Section 3.

 

c)                  
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and
in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company
will make and deliver a new Warrant or certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or certificate.

 

d)                  
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

 

 

 

    	 	11	 

     

    

 

e)                  
Authorized Shares.

 

The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued shares of Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant (the “Required
Reserve Amount”). The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The
Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.
The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant
will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be
duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect
of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.

 

Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.

 

f)                  
Governing Law. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning
the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of California,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of California or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of California. The Company hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the
Company at the address set forth on the signature page of the Purchase Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and
federal courts sitting in Los Angeles County, California, for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or
proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is
brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.

 

g)                  
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, may have restrictions upon resale imposed by state and federal or foreign securities
laws.

 

 

 

 

    	 	12	 

     

    

 

h)                  
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other
provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

i)                  
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company
shall be delivered in accordance with the notice provisions of the Purchase Agreement.

 

j)                  
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the
Holder for the purchase price of any shares of Common Stock or as a shareholder of the Company, whether such liability is asserted by
the Company or by creditors of the Company.

 

k)                  
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.

 

l)                  
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.

 

m)                 
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.

 

n)                 
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and
valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

o)                 
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.

 

********************

 

(Signature Page Follows)

 

 

    	 	13	 

     

    

 

IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

 

	 	
    Esports Technologies, Inc.

     

     

	 	
    By:__________________________________________

    Name: James Purcell

    Title: Chief Financial Officer

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	14	 

     

    

 

NOTICE OF EXERCISE

 

To:     Esports
Technologies, Inc.

 

 

(1)  
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the
terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.

 

(2)  
Payment shall take the form of (check applicable box):

 

[  ] in lawful money
of the United States; or

 

[  ] if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).

 

(3)  
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified
below:

 

 

_______________________________

 

 

The Warrant Shares shall be delivered to the following
DWAC Account Number:

 

_______________________________

 

_______________________________

 

_______________________________

 

 

[SIGNATURE
OF HOLDER]

 

Name of Investing Entity: _______________________________________________________________________

Signature of Authorized Signatory of Investing
Entity: _________________________________________________

Name of Authorized Signatory: ___________________________________________________________________

Title of Authorized Signatory: ____________________________________________________________________

Date: ________________________________________________________________________________________

 

 

 

 

    	 	15	 

     

    

 

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 
	 	(Please Print)
	 	 
	Address:	 
	
     

    
	
    (Please Print)

	 	 
	Phone
    Number:	 
	 	 
	Email
    Address:	 
	 	 
	Dated: _______________ __, ______	 
	Holder’s Signature: ______________________________	 
	Holder’s Address: _______________________________	 

 

 

 

 

 

 

 

 

 

    	 	16Exhibit 4.3

 

NEITHER THIS SECURITY
NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

ESPORTS TECHNOLOGIES,
INC.

 

WARRANT TO PURCHASE
COMMON STOCK

 

	 	 	
    Number of Shares: 1,567,840

    (subject to adjustment)

	Warrant No. CP-1	 	Original Issue Date: November 29, 2021

 

Esports Technologies,
Inc., a Nevada corporation (the “Company”), hereby certifies that, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, CP BF Lending, LLC or its permitted registered assigns (the “Holder”),
is entitled, subject to the terms set forth below, to purchase from the Company up to a total of 1,567,840 shares of common stock, $0.001
par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share”
and all such shares, the “Warrant Shares”) at an exercise price per share equal to $25.00 per share (as adjusted
from time to time as provided in Section 9 herein, the “Exercise Price”), upon surrender of this Warrant
to purchase Common Stock (including any Warrants to purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”)
at any time and from time to time on or after the date hereof (the “Original Issue Date”) and through and including
5:30 P.M., New York City time, on the date that is the earlier to occur of (i) five (5) years following the Original Issue Date or (ii)
the second anniversary of the satisfaction of all obligations of the Company under that certain Credit Agreement (the “Credit
Agreement”) among the Company, certain subsidiaries of the Company and CP BF Lending, LLC dated as of the date hereof
(the “Expiration Date”), and subject to the following terms and conditions:

 

1. Definitions.
For purposes of this Warrant, the following terms shall have the following meanings:

 

“Acquisition”
means the Company’s acquisition of Karamba Limited, a limited liability company incorporate and existing under the laws of Malta
bearing registration number C99777.

 

“Affiliate”
means any Person directly or indirectly controlled by, controlling or under common control with, a Holder, but only for so long as such
control shall continue. For purposes of this definition, “control” (including, with correlative meanings, “controlled
by,” “controlling” and “under common control with”) means, with respect to a Person, possession, direct
or indirect, of (a) the power to direct or cause direction of the management and policies of such Person (whether through ownership
of securities or partnership or other ownership interests, by contract or otherwise), or (b) at least 50% of the voting securities
(whether directly or pursuant to any option, warrant or other similar arrangement) or other comparable equity interests.

 

“Alternate
Consideration” has the meaning set forth in Section 9(c).

 

“Business
Day” means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of Seattle, Washington
are authorized or obligated by law or executive order to close.

 

 

 

 

    	 	1	 

     

    

 

“Buy-In”
has the meaning set forth in Section 5(b).

 

“Buy-In Price”
has the meaning set forth in Section 5(b).

 

“Closing
Sale Price” means, for any security as of any date, the last trade price for such security on the Principal Trading Market
for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended hours
basis and does not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City time,
as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter market
on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or, if no last trade price is reported
for such security by Bloomberg Financial Markets, the average of the bid and ask prices, of any market makers for such security as reported
in the “pink sheets” by Pink Sheets LLC. If the Closing Sale Price cannot be calculated for a security on a particular date
on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined
by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the
fair market value shall be determined by an appraiser selected by the Holder reasonably acceptable to the Company. The appraiser’s
determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for
any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common Stock”
has the meaning set forth in the preamble.

 

“Common Stock
Deemed Outstanding” shall mean the number of shares of Common Stock outstanding immediately prior to such issuance or deemed
issuance of the aggregate number of shares of Common Stock issued or sold (or deemed issued or sold) by the Company in such issuance or
sale (or deemed issuance or sale) (treating for this purpose as outstanding all shares of Common Stock issuable upon exercise of Options
outstanding immediately prior to such issuance or deemed issuance or upon conversion or exchange of Convertible Securities outstanding
(assuming exercise of any outstanding Options therefor) immediately prior to such issue);

 

“Convertible
Securities” means any shares or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any Common
Stock.

 

“Credit Agreement”
has the meaning set forth in the preamble.

 

“Distributed
Property” has the meaning set forth in Section 9(b).

 

“Effectiveness
Deadline” has the meaning set forth in Section 12.

 

“Exempt Issuance”
means the issuance of (a) Common Stock or Options to employees, officers, directors or consultants of the Company pursuant to any equity
plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of
a committee of non-employee directors established for such purpose for services rendered to the Company; (b) securities issued pursuant
to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that any such
issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company
or an owner of an asset in a business synergistic with the current business of the Company at such time and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities; (c) Series A Preferred
Stock and warrants to purchase Common Stock to be issued in connection with the Acquisition and the issuance of Common Stock upon the
conversion of the Series A Preferred Stock and exercise of the foregoing warrants; (d) Common Stock upon the exercise or conversion of
any Convertible Securities outstanding on the date hereof; and (e) Common Stock and Convertible Securities (and Common Stock issuable
thereunder) issued in connection with the Acquisition.

 

 

    	 	2	 

     

    

 

“Exercise
Date” has the meaning set forth in Section 4(b).

 

“Exercise
Notice” has the meaning set forth in Section 4(b).

 

“Exercise
Price” has the meaning set forth in the preamble.

 

“Expiration
Date” has the meaning set forth in the preamble.

 

“Filing Deadline”
has the meaning set forth in Section 12.

 

“Fundamental
Transaction” has the meaning set forth in Section 9(c).

 

“Holder Counsel”
has the meaning set forth in Section 12.

 

“Maximum
Percentage” has the meaning set forth in Section 11.

 

“New Warrant”
has the meaning set forth in Section 3.

 

“Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

“Principal
Trading Market” means the national securities exchange or other trading market on which the Common Stock is primarily listed
on and quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Capital Market.

 

“Resale Registration
Statement” has the meaning set forth in Section 12.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Shareholder
Approval” has the meaning set forth in Section 16(m).

 

“Shareholder
Meeting” has the meaning set forth in Section 16(m).

 

“Shareholder
Meeting Deadline” has the meaning set forth in Section 16(m).

 

“Shareholder
Resolutions” has the meaning set forth in Section 16(m).

 

“Suspension
Event” has the meaning set forth in Section 12.

 

“Trading
Day” means any weekday on which the Principal Trading Market is open for trading.

 

“Trading
Market” means the Nasdaq Capital Market and or any other exchanges on which the Common Stock is listed or quoted for trading
on the date in question.

 

 

 

    	 	3	 

     

    

 

“Transfer
Agent” means Continental Stock Transfer & Trust Company, the Company’s transfer agent and registrar for the Common
Stock, and any successor appointed in such capacity.

 

“Underwritten
Registration Statement” has the meaning set forth in Section 12.

 

“Warrant”
has the meaning set forth in the preamble.

 

“Warrant
Register” has the meaning set forth in Section 2.

 

“Warrant
Share(s)” has the meaning set forth in the preamble and shall include all securities received (i) in replacement of
the Warrant Shares, (ii) as a result of the adjustments set forth in Section 9.

 

2. Registration
of Warrants. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant
Register”), in the name of the record Holder (which shall include the initial Holder or, as the case may be, any registered
assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.

 

3. Registration
of Transfers. Subject to compliance with all applicable securities laws, the Company shall, or will cause its Transfer Agent to, register
the transfer of all or any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, and payment for all applicable
transfer taxes (if any). Upon any such registration or transfer, a new warrant to purchase Common Stock in substantially the form of this
Warrant (any such new warrant, a “New Warrant”) evidencing the portion of this Warrant so transferred shall
be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued
to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee
of all of the rights and obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company shall,
or will cause its Transfer Agent to, prepare, issue and deliver at the Company’s own expense any New Warrant under this Section
3. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the owner and holder
for all purposes, and the Company shall not be affected by any notice to the contrary.

 

4. Exercise and
Duration of Warrants.

 

(a) All or any part of
this Warrant shall be exercisable by the registered Holder in any manner permitted by Section 10 of this Warrant at any time and
from time to time on or after the Original Issue Date and through and including 5:30 P.M. New York City time, on the Expiration Date.
At 5:30 P.M., New York City time, on the Expiration Date, if the Resale Registration Statement is not effective, without any action on
the part of the Holder, the Warrant shall be deemed to have be exercised as a “cashless exercise” in accordance with Section
10 below.

 

(b) The Holder may exercise
this Warrant by delivering to the Company (i) an exercise notice, in the form attached as Schedule 1 hereto (the “Exercise
Notice”), completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares as to which
this Warrant is being exercised, and the date on which the last of such items is delivered to the Company (as determined in accordance
with the notice provisions hereof) is an “Exercise Date.” The Holder shall not be required to deliver the original
Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the same effect as cancellation
of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number of Warrant Shares. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required.

 

 

 

 

    	 	4	 

     

    

 

5. Delivery of
Warrant Shares.

 

(a) Upon exercise of
this Warrant, the Company shall promptly (but in no event later than two Trading Days after the Exercise Date), credit such aggregate
number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s
balance account with The Depository Trust Company (“DTC”) through its Deposit Withdrawal Agent Commission system,
or if the Holder exercises this Warrant at a time when the Holder may not sell the Warrant Shares without restriction or limitation either
(I) pursuant to Rule 144 of the Securities Act and without the requirement to be in compliance with Rule 144(c)(1) of the Securities Act
(or the Holder does not undertake to resell such Warrant Shares promptly after issuance while the Company is in compliance with the public
information requirements of Rule 144(c)(1)) or (II) pursuant to an effective registration statement registering the resale of the Warrant
Shares, then the Company may satisfy the delivery of Warrant Shares via book-entry that may bear a legend regarding restriction on transferability,
and the Company shall issue and dispatch by overnight courier to the address as specified in the Exercise Notice, a book-entry confirmation,
registered in the Company’s share register in the name of the Holder or its designee, for the number of shares of Common Stock to
which the Holder is entitled pursuant to such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. The Holder, or any natural person or legal entity (each, a “Person”)
permissibly so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant
Shares as of the Exercise Date, irrespective of the date such Warrant Shares are credited to the Holder’s DTC account or the date
of delivery of the certificates evidencing such Warrant Shares, as the case may be.

 

(b) If by the close of
the second Trading Day after (i) the Exercise Date or (ii) the date of sale with respect to any Warrant Shares that are sold in accordance
with Rule 144 of the Securities Act or which have been held for more than one year (assuming Holder is not an Affiliate), the Company
fails to deliver to the Holder a book-entry confirmation representing the required number of Warrant Shares in the manner required pursuant
to Section 5(a) or fails to credit the Holder’s balance account with DTC for such number of Warrant Shares to which the Holder
is entitled or fails to remove any restrictions on such Warrant Shares sold, and if after such second Trading Day and prior to the receipt
of such Warrant Shares or removal of legends on issued Warrant Shares, the Holder purchases (in an open market transaction or otherwise)
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise or sale (a “Buy-In”), then the Company shall, within two Trading Days after the Holder’s
request and in the Holder’s sole discretion, either (1) pay in cash to the Holder an amount equal to the Holder’s total purchase
price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the “Buy-In Price”),
at which point the Company’s obligation to deliver such book-entry confirmation (and to issue such Warrant Shares) or removal of
legends on book-entry shares shall terminate or (2) promptly honor its obligation to deliver to the Holder a book-entry confirmation representing
such Warrant Shares and pay cash to the Holder in an amount equal to the excess (if any) of Holder’s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased in the Buy-In less the product of (A) the number of shares
of Common Stock purchased in the Buy-In, times (B) the Closing Sale Price of a share of Common Stock on the Exercise Date or applicable
sale date.

 

(c) To the extent permitted
by law and subject to Section 5(b), the Company’s obligations to issue and deliver Warrant Shares in accordance with and
subject to the terms hereof (including the limitations set forth in Section 11 below) are absolute and unconditional, irrespective
of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery
of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination,
or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation
of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise limit such obligation of the
Company to the Holder in connection with the issuance of Warrant Shares. Subject to Section 5(b), nothing herein shall limit the
Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver a book-entry confirmation
representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

6. Charges, Taxes
and Expenses. Issuance and delivery of certificates for shares of Common Stock upon exercise of this Warrant shall be made without
charge to the Holder for any issue or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp
duties) in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however,
that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any
certificates for Warrant Shares or the Warrants in a name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible
for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise
hereof.

 

 

 

    	 	5	 

     

    

 

7. Replacement
of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and
substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of
evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and reasonable
indemnity, if requested by the Company. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable
regulations and procedures. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such
mutilated Warrant to the Company as a condition precedent to the Company’s obligation to issue the New Warrant.

 

8. Company’s
Representations, Warranties, and Covenants. The Company hereby represents, warrants, covenants and agrees as follows:

 

(i) The Company will
at all times while this Warrant is outstanding reserve and keep available out of the aggregate of its authorized but unissued and otherwise
unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant as herein provided,
the number of Warrant Shares that are initially issuable and deliverable upon the exercise of this entire Warrant, free from preemptive
rights or any other contingent purchase rights of persons other than the Holder (taking into account the adjustments and restrictions
of Section 9).

 

(ii) All Warrant Shares
so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof,
be duly and validly authorized, issued and fully paid and nonassessable.

 

(iii) The Company will
take all such action as may be reasonably necessary to assure that such shares of Common Stock may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation system upon which
the Common Stock may be listed.

 

(iv) The Company shall
not grant to any person or entity registration rights relating to the Company’s Securities which conflict with or limit the rights
of the Company to have the Warrant Shares registered for sale in accordance with Section 12.

 

9. Certain Adjustments.
The number of Warrant Shares issuable upon exercise of this Warrant is subject to adjustment from time to time as set forth in this Section 9.

 

(a) Stock Dividends
and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise
makes a distribution on any class of capital stock issued and outstanding on the Original Issue Date and in accordance with the terms
of such stock on the Original Issue Date or as amended, that is payable in shares of Common Stock, (ii) subdivides its outstanding
shares of Common Stock into a larger number of shares of Common Stock, (iii) combines its outstanding shares of Common Stock into
a smaller number of shares of Common Stock or (iv) issues by reclassification of shares of capital stock any additional shares of
Common Stock of the Company, then in each such case the number of Warrant Shares then underlying this Warrant shall be divided by a fraction,
the numerator of which shall be the number of shares of Common Stock outstanding immediately before such event and the denominator of
which shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of
this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such
dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully paid on the
date fixed therefor, the number of Warrant Shares shall be recomputed accordingly as of the close of business on such record date and
thereafter the Warrant Shares shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends. Any adjustment
pursuant to clauses (i), (ii), or (iii) of this Section 9(a) shall become effective immediately after the effective date of such
subdivision or combination.

 

 

 

    	 	6	 

     

    

 

(b) Pro Rata
Distributions. If the Company, at any time while this Warrant is outstanding, distributes to all holders of Common Stock for no consideration
(i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Stock covered by the preceding paragraph),
(iii) rights or warrants to subscribe for or purchase any security, or (iv) cash or any other asset (in each case, “Distributed
Property”), then, upon any exercise of this Warrant that occurs after the record date fixed for determination of stockholders
entitled to receive such distribution, the Holder shall be entitled to receive, in addition to the Warrant Shares otherwise issuable upon
such exercise (if applicable), the Distributed Property that such Holder would have been entitled to receive in respect of such number
of Warrant Shares had the Holder been the record holder of such Warrant Shares immediately prior to such record date without regard to
any limitation on exercise contained therein.

 

(c) Fundamental
Transactions. If, at any time while this Warrant is outstanding (i) the Company effects any merger or consolidation of the Company
with or into another Person, in which the Company is not the surviving entity or the stockholders of the Company immediately prior to
such merger or consolidation do not own, directly or indirectly, at least 50.0% of the voting power of the surviving entity immediately
after such merger or consolidation, (ii) the Company effects any sale to another Person of all or substantially all of its assets
in one transaction or a series of related transactions, (iii) pursuant to any tender offer or exchange offer (whether by the Company
or another Person), holders of capital stock who tender shares representing equal to or more than 50.0% of the voting power of the capital
stock of the Company and the Company or such other Person, as applicable, accepts such tender for payment, (iv) the Company consummates
a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or
scheme of arrangement) with another Person whereby such other Person acquires equal to or more than 50.0% of the voting power of the capital
stock of the Company (except for any such transaction in which the stockholders of the Company immediately prior to such transaction maintain,
in substantially the same proportions, the voting power of such Person immediately after the transaction) or (v) the Company effects
any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock
covered by Section 9(a) above) (in any such case, a “Fundamental Transaction”), then following
such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and kind of securities,
cash or property as Holder would have been entitled to receive upon the occurrence of such Fundamental Transaction as if Holder had been,
immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this
Warrant without regard to any limitations on exercise contained herein (the “Alternate Consideration”). The
Company shall not effect any Fundamental Transaction in which the Company is not the surviving entity or the Alternate Consideration includes
securities of another Person unless (i) the Alternate Consideration is solely cash and the Company provides for the simultaneous
“cashless exercise” of this Warrant pursuant to Section 10 below or (ii) prior to or simultaneously with the consummation
thereof, any successor to the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume
the obligation to deliver to the Holder, such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may
be entitled to receive, and the other obligations under this Warrant. The provisions of this Section 9(c) shall similarly
apply to subsequent transactions analogous of a Fundamental Transaction type.

 

(d) Adjustment
to Exercise Price and Number of Warrant Shares Upon Issuance or Deemed issuance of Common Stock.

 

(i) Adjustment
to Exercise Price Upon Issuance of Common Stock. Except in the case of an event described in Section 9(a), Section 9(b)
or Section 9(c), if the Company shall, at any time or from time to time after the Original Issue Date, issue or sell, or in accordance
with Section 9(d)(iv), is deemed to have issued or sold, any shares of Common Stock without consideration or for consideration
per share less than the Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance or sale), then immediately
upon such issuance or sale (or deemed issuance or sale), the Exercise Price shall be reduced to an Exercise Price as is computed using
the following formula: X =(A x B + C) ÷ (A + D)

 

Where:

 

X = the
reduced Exercise Price.

 

A = the Common
Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale).

 

B = the Exercise
Price then in effect immediately prior to such issuance or sale (or deemed issuance or sale).

 

C = the aggregate
consideration, if any, received by the Company upon such issuance or sale (or deemed issuance or sale).

 

D = the aggregate
number of shares of Common Stock issued or sold (or deemed issued or sold) by the Company in such issuance or sale (or deemed issuance
or sale).

 

 

 

    	 	7	 

     

    

 

(ii) Adjustment
to Number of Warrant Shares Upon Adjustment to Exercise Price. Subject to and conditioned upon Shareholder Approval as provided in
Section 16(m), upon any and each adjustment of the Exercise Price as provided in Section 9(d)(i), the number of Warrant
Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment shall be increased to a number of Warrant Shares
as is computed using the following formula: X' = X(Y ÷ Y')

 

Where:

X' = the adjusted
total number of Warrant Shares issuable upon exercise of the Warrant immediately following the adjustment of the Exercise Price.

 

X = the total
number of Warrant Shares previously issuable upon exercise of the Warrant immediately prior to the adjustment of the Exercise Price.

 

Y = the Exercise
Price immediately prior to the adjustment.

 

Y' = the adjusted
Exercise Price pursuant to Section 9(a)(i).

 

(iii) Exceptions
to Adjustment Upon Issuance of Common Stock. Anything herein to the contrary notwithstanding, there shall be no adjustment to the
Exercise Price or the number of Warrant Shares issuable upon exercise of this Warrant with respect to any Exempt Issuance.

 

(iv) Effect
of Certain Events on Adjustment to Exercise Price. For purposes of determining the adjusted Exercise Price under Section 9(a)(i),
the following shall be applicable:

 

(A) Issuance
of Options. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner grant or sell (whether
directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to convert or exchange any Convertible
Securities issuable upon the exercise of such Options are immediately exercisable, and the price per share (determined as provided in
this paragraph and in Section 9(d)(iv)(E) for which Common Stock is issuable upon the exercise of such Options or upon the conversion
or exchange of Convertible Securities issuable upon the exercise of such Options is less than the Exercise Price in effect immediately
prior to the time of the granting or sale of such Options, then the total maximum number of shares of Common Stock issuable upon the exercise
of such Options or upon conversion or exchange of the total maximum amount of Convertible Securities issuable upon the exercise of such
Options shall be deemed to have been issued as of the date of granting or sale of such Options (and thereafter shall be deemed to be outstanding
for purposes of adjusting the Exercise Price under Section 9(d)(i)), at a price per share equal to the quotient obtained by dividing
(A) the sum (which sum shall constitute the applicable consideration received for purposes of Section 9(d)(i)) of (x) the total amount,
if any, received or receivable by the Company as consideration for the granting or sale of all such Options, plus (y) the minimum
aggregate amount of additional consideration payable to the Company upon the exercise of all such Options, plus (z), in the case
of such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable to the
Company upon the issuance or sale of all such Convertible Securities and the conversion or exchange of all such Convertible Securities,
by (B) the total maximum number of shares of Common Stock issuable upon the exercise of all such Options or upon the conversion or exchange
of all Convertible Securities issuable upon the exercise of all such Options. Except as otherwise provided in Section 9(d)(iv)(C),
no further adjustment of the Exercise Price shall be made upon the actual issuance of Common Stock or of Convertible Securities upon exercise
of such Options or upon the actual issuance of Common Stock upon conversion or exchange of Convertible Securities issuable upon exercise
of such Options.

 

 

 

    	 	8	 

     

    

 

(B) Issuance
of Convertible Securities. If the Company shall, at any time or from time to time after the Original Issue Date, in any manner grant
or sell (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert or
exchange any such Convertible Securities is immediately exercisable, and the price per share (determined as provided in this paragraph
and in Section 9(d)(iv)(E)) for which Common Stock is issuable upon the conversion or exchange of such Convertible Securities is
less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Convertible Securities, then the
total maximum number of shares of Common Stock issuable upon conversion or exchange of the total maximum amount of such Convertible Securities
shall be deemed to have been issued as of the date of granting or sale of such Convertible Securities (and thereafter shall be deemed
to be outstanding for purposes of adjusting the Exercise Price pursuant to Section 9(d)(i)), at a price per share equal to the
quotient obtained by dividing (A) the sum (which sum shall constitute the applicable consideration received for purposes of Section
9(d)(i)) of (x) the total amount, if any, received or receivable by the Company as consideration for the granting or sale of such
Convertible Securities, plus (y) the minimum aggregate amount of additional consideration, if any, payable to the Company upon
the conversion or exchange of all such Convertible Securities, by (B) the total maximum number of shares of Common Stock issuable upon
the conversion or exchange of all such Convertible Securities. Except as otherwise provided in Section 9(d)(iv)(C), no further
adjustment of the Exercise Price shall be made upon the actual issuance of Common Stock upon conversion or exchange of such Convertible
Securities or the issue or sale of Convertible Securities upon exercise of any Options to purchase any such Convertible Securities for
which adjustments of the Exercise Price have been made pursuant to the other provisions of this Section 9(d)(iv).

 

(C) Change
in Terms of Options or Convertible Securities. Upon any change in any of (A) the total amount received or receivable by the Company
as consideration for the granting or sale of any Options or Convertible Securities referred to in Section 9(d)(iv)(A) or Section
9(d)(iv)(B) hereof, (B) the minimum aggregate amount of additional consideration, if any, payable to the Company upon the exercise
of any Options or upon the issuance, conversion or exchange of any Convertible Securities referred to in Section 9(d)(iv)(A) or
Section 9(d)(iv)(B), (C) the rate at which Convertible Securities referred to in Section 9(d)(iv)(A) or Section 9(d)(iv)(B)
are convertible into or exchangeable for Common Stock, or (D) the maximum number of shares of Common Stock issuable in connection with
any Options referred to in Section 9(d)(iv)(A) hereof or any Convertible Securities referred to in Section 9(d)(iv)(B)
hereof (in each case, other than in connection with an Excluded Issuance), then (whether or not the original issuance or sale of such
Options or Convertible Securities resulted in an adjustment to the Exercise Price pursuant to this Section 9(d), the Exercise Price
in effect at the time of such change shall be adjusted or readjusted, as applicable, to the Exercise Price which would have been in effect
at such time pursuant to the provisions of this Section 9(d) had such Options or Convertible Securities still outstanding provided
for such changed consideration, conversion rate or maximum number of shares, as the case may be, at the time initially granted, issued
or sold, but only if as a result of such adjustment or readjustment the Exercise Price then in effect is reduced, and the number of Warrant
Shares issuable upon the exercise of this Warrant immediately prior to any such adjustment or readjustment shall be correspondingly adjusted
or readjusted pursuant to the provisions of Section 9(d)(ii).

 

(D) Treatment
of Expired or Terminated Options or Convertible Securities. Upon the expiration or termination of any unexercised Option (or portion
thereof) or any unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either upon its original
issuance or upon a revision of its terms) was made pursuant to this Section 9(d) (including without limitation upon the redemption
or purchase for consideration of all or any portion of such Option or Convertible Security by the Company), the Exercise Price then in
effect hereunder shall forthwith be changed pursuant to the provisions of this Section 9(d) to the Exercise Price which would have
been in effect at the time of such expiration or termination had such unexercised Option (or portion thereof) or unconverted or unexchanged
Convertible Security (or portion thereof), to the extent outstanding immediately prior to such expiration or termination, never been issued.

 

 

 

    	 	9	 

     

    

 

(E) Calculation
of Consideration Received. If the Company shall, at any time or from time to time after the Original Issue Date, issue or sell, or
is deemed to have issued or sold in accordance with Section 9(d)(iv), any shares of Common Stock, Options or Convertible Securities:
(A) for cash, the consideration received therefor shall be deemed to be the net amount received by the Company therefor; (B) for consideration
other than cash, the amount of the consideration other than cash received by the Company shall be the fair value of such consideration,
except where such consideration consists of marketable securities that have traded at an average daily trading volume of at least $1,000,000
during the 30 day period immediately preceding the date of receipt of such securities, in which case the amount of consideration received
by the Company shall be the market price (as reflected on any securities exchange, quotation system or association or similar pricing
system covering such security) for such securities as of the end of business on the date of receipt of such securities; (C) for no specifically
allocated consideration in connection with an issuance or sale of other securities of the Company, together comprising one integrated
transaction, the amount of the consideration therefor shall be deemed to be $0.01; or (D) to the owners of the non-surviving entity in
connection with any merger in which the Company is the surviving corporation, the amount of consideration therefor shall be deemed to
be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common
Stock, Options or Convertible Securities, as the case may be, issued to such owners. The net amount of any cash consideration and the
fair value of any consideration other than cash or marketable securities shall be determined in good faith jointly by the Board and the
Holder. In the event that the Company and Holder are unable agree on the fair value of any non-cash consideration within ten (10) Business
Days, Holder shall appoint a qualified independent third party to calculate the fair value. The calculation made by such independent third
party shall be final and binding. The Company shall be responsible for all costs of such third party.

 

(e) Record
Date. For purposes of any adjustment to the Exercise Price or the number of Warrant Shares in accordance with this Section 9(d),
in case the Company shall take a record of the holders of its Common Stock for the purpose of entitling them (A) to receive a dividend
or other distribution payable in Common Stock, Options or Convertible Securities or (B) to subscribe for or purchase Common Stock, Options
or Convertible Securities, then such record date shall be deemed to be the date of the issue or sale of the shares of Common Stock deemed
to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting
of such right of subscription or purchase, as the case may be

 

(f) Calculations.
All calculations under this Section 9 shall be made to the nearest share.

 

(g) Notice of
Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will promptly, but
in any event not later than three (3) Business Days, (i) compute such adjustment, in good faith, in accordance with the terms of this
Warrant, (ii) prepare a certificate setting forth such adjustment, including a statement of the adjusted number or type of Warrant Shares
or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments
and showing in detail the facts upon which such adjustment is based, and (iii) deliver a copy of each such certificate to the Holder and
to the Company’s transfer agent. Holder shall have the right to dispute the adjustment calculation within ten (10) Business Days
following receipt of notice. The Company and Holder shall negotiate in good faith to resolve any disagreement. In the event that the Company
and Holder are unable to resolve such disagreement, Holder shall appoint a qualified independent third party to calculate the adjustment
amount. The calculation made by such independent third party shall be final and binding. The Company shall be responsible for all costs
of such third party.

 

(h) Notice of
Corporate Events. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution of cash,
securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe
for or purchase any capital stock of the Company or any subsidiary, (ii) authorizes or approves, enters into any agreement contemplating
or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding
up of the affairs of the Company, then, except if such notice and the contents thereof shall be deemed to constitute material non-public
information, the Company shall deliver to the Holder a notice of such transaction at least thirty (30) days prior to the applicable
record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction.
In addition, if while this Warrant is outstanding, the Company authorizes or approves, enters into any agreement contemplating or solicits
stockholder approval for any Fundamental Transaction contemplated by Section 9(c), other than a Fundamental Transaction under clause
(iii) of Section 9(c), the Company shall deliver to the Holder a notice of such Fundamental Transaction at least thirty (30) days
prior to the date such Fundamental Transaction is consummated. Holder agrees to maintain any information disclosed pursuant to this Section
9(h) in confidence until such information is publicly available, and shall comply with applicable law with respect to trading in the
Company’s securities following receipt any such information.

 

 

 

    	 	10	 

     

    

 

10. Payment of
Exercise Price. Notwithstanding anything contained herein to the contrary, in the event that this Warrant shall be deemed to be automatically
exercised in accordance with Section 4(a) or exercised in accordance with Section 9(c), the Holder shall be deemed to have
satisfied its obligation to pay the Exercise Price through a “cashless exercise,” in which event the Company shall issue to
the Holder the number of Warrant Shares as is computed using the following formula: X = Y [(A-B)/A]

 

where:

 

“X”
= the number of Warrant Shares to be issued to the Holder;

 

“Y”
= the total number of Warrant Shares with respect to which this Warrant is then being exercised;

 

“A”
= the Closing Sale Price of the shares of the Common Stock (as reported by Bloomberg Financial Markets) on the Trading Day ending on the
date immediately preceding the Exercise Date; and

 

“B”
= the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

For purposes of Rule 144 promulgated under
the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a “cashless exercise” transaction
shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced,
on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper
at the time of such exercise).

 

11. Limitations
on Exercise.

 

(a) Notwithstanding anything
to the contrary contained herein, the Company shall not effect any exercise of this Warrant, and the Holder shall not be entitled to exercise
this Warrant for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving effect or immediately prior
to such exercise, would cause (i) the aggregate number of shares of Common Stock beneficially owned as calculated in accordance with
Section 13(d) of the United States Securities Exchange Act of 1934, as amended, by the Holder, its Affiliates and any Persons who are
members of a Section 13(d) group with such Holder or its Affiliates to exceed 4.99% (the “Maximum Percentage”)
of the total number of issued and outstanding shares of Common Stock of the Company following such exercise, or (ii) the combined
voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other Persons who are members
of a Section 13(d) group with such Holder or its Affiliates to exceed the Maximum Percentage of the combined voting power of all of the
securities of the Company then outstanding following such exercise. For purposes of this Warrant, in determining the number of outstanding
shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company’s
most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K, as the case may be, filed with the Commission prior to the
date hereof, (y) a more recent public announcement by the Company or (z) any other notice by the Company or the Transfer Agent
setting forth the number of shares of Common Stock outstanding. Upon the written request of the Holder, the Company shall within three
(3) Trading Days confirm in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder since the date as of which such number of outstanding shares of Common Stock was
reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other
percentage specified not in excess of 19.99% specified in such notice. For purposes of this Section 11(a), the aggregate number
of shares of Common Stock or voting securities beneficially owned by the Holder and its Affiliates and any other Persons who are members
of a Section 13(d) group with such Holder or its Affiliates shall include the shares of Common Stock issuable upon (x) the exercise of
this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would
be issuable upon exercise of the remaining unexercised and non-cancelled portion of this Warrant by the Holder and (y) the exercise or
conversion of the unexercised, non-converted or non-cancelled portion of any other securities of the Company that do not have voting power
(including without limitation any securities of the Company which would entitle the holder thereof to acquire at any time Common Stock,
including without limitation any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into
or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock), is subject to a limitation on
conversion or exercise analogous to the limitation contained herein and is beneficially owned by the Holder or any of its Affiliates and
other Persons who are members of a Section 13(d) group with such Holder or its Affiliates.

 

 

 

    	 	11	 

     

    

 

(b) This Section 11
shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount
of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section
9 of this Warrant.

 

12. Registration Rights.

 

(a) Registration.
The Company shall use commercially reasonable efforts to file as soon as reasonably practicable, but in any event no later than 45 calendar
days after the Closing (the “Filing Deadline”), and use commercially reasonable efforts to cause to be declared
effective as soon as reasonably practicable thereafter, a registration statement filed with the Commission (the “Resale Registration
Statement”) registering the resale of all of the Warrant Shares (the “Effectiveness Deadline”);
provided, that the Company’s obligations to include the Warrant Shares in the Resale Registration Statement are contingent upon
Holder furnishing in writing to the Company such information regarding Holder, the securities of the Company held by Holder and the intended
method of disposition of the Warrant Shares held by Holder (which shall be limited to non-underwritten public offerings) to the extent
required as shall be reasonably requested by the Company to effect the registration of the Warrant Shares held by Holder, and Holder shall
execute such documents in connection with such registration as the Company may reasonably request to the extent required. The Company
agrees to use commercially reasonable efforts to keep such Resale Registration Statement, or another shelf registration statement that
includes the Warrant Shares, effective with respect to each Holder until the earliest of (x) the date on which Holder ceases to hold any
Warrant Shares issued pursuant to this Agreement, and (y) the first date on which Holder is able to sell all of its Warrant Shares in
a 90-day period without registration under Rule 144 of the Securities Act or any successor rule (but with no volume or other restrictions
or limitations including as to manner or timing of sale); provided, that the Company shall be entitled to delay or postpone the effectiveness
of the Resale Registration Statement, and from time to time require the Holder not to sell under the Resale Registration Statement or
suspend effectiveness thereof, if it reasonably determines in good faith that in order for the Resale Registration Statement not to contain
a material misstatement or omission, (i) the negotiation or consummation of a transaction by the Company or its subsidiaries is pending
or another event has occurred, which negotiation, consummation or (ii) other event the Company’s Board of Directors reasonably and
in good faith believes would require additional disclosure by the Company in the Resale Registration Statement of material information
that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Resale Registration
Statement would be expected, in the reasonable determination of the Company’s board of directors, to cause the Resale Registration
Statement to fail to comply with applicable disclosure requirements (such circumstance, a “Suspension Event”);
provided, however, that the Company may not delay or suspend the Resale Registration Statement on more than two occasions or for more
than 60 consecutive calendar days, or more than 90 calendar days in the aggregate, in each case during any 12-month period. Upon receipt
of written notice from the Company (which notice shall not contain any material non-public information regarding the Company) of the happening
of any Suspension Event during the period that the Resale Registration Statement is effective or if as a result of a Suspension Event
the Resale Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made
(in the case of the prospectus) not misleading, each Holder hereby agrees that (i) it will immediately discontinue offers and sales of
the Warrant Shares under the Resale Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144)
until Holder receives copies of a supplemental or amended prospectus (which the Company agrees to promptly prepare) that corrects the
misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment has become effective or unless
otherwise notified by the Company that it may resume such offers and sales, and (ii) it will maintain the confidentiality of any information
included in such written notice delivered by the Company unless otherwise required by law or subpoena. If so directed by the Company,
Holder will deliver to the Company or, in Holder’s sole discretion destroy, all copies of the prospectus covering the Warrant Shares
in Holder’s possession; provided, however, that this obligation to deliver or destroy all copies of the prospectus covering the
Warrant Shares shall not apply (A) to the extent Holder is required to retain a copy of such prospectus (I) in order to comply with applicable
legal, regulatory, self-regulatory or professional requirements or (II) in accordance with a bona fide pre-existing document retention
policy or (B) to copies stored electronically on archival servers as a result of automatic data back-up. Holder shall not in connection
with the foregoing be required to execute any lock up or similar agreement or otherwise be subject to any contractual restriction on the
ability to transfer the Warrant Shares. Any failure by Company to file the Resale Registration Statement by the Filing Deadline or to
effect such Resale Registration Statement by the Effectiveness Deadline shall not otherwise relieve the Company of its obligations to
file or effect the Resale Registration Statement as set forth in this Section 12(a).

 

 

    	 	12	 

     

    

 

(b)        Piggyback
Registration.

 

(i) If the
Company proposes to register any of its securities under the Securities Act in connection with an underwritten public offering of such
securities solely for cash)(the “Underwritten Registration Statement”), the Company shall, at such time, promptly
give Holder notice of such underwritten registration. Upon the request of Holder given within twenty (20) days after such notice is given
by the Company, the Company shall, subject to the provisions of Section 12(b)(ii), cause to be registered all of the Warrant Shares
that Holder has requested to be included in such Underwritten Registration Statement. The Company shall have the right to terminate or
withdraw any Underwritten Registration Statement initiated by it under this Section 12(b) before the effective date of such Underwritten
Registration Statement, whether or not any Holder has elected to include Warrant Shares in such Underwritten Registration Statement.

 

(ii) The Company
shall not be required to include any of the Holders’ Warrant Shares in such Underwritten Registration Statement unless the Holder
accepts the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters
in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities,
including Warrant Shares, requested by stockholders to be included in such offering exceeds the number of securities to be sold (other
than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then
the Company shall be required to include in the offering only that number of such securities, including Warrant Shares, which the underwriters
and the Company in their sole discretion determine will not jeopardize the success of the offering. Notwithstanding the foregoing, in
no event shall the number of Warrant Shares included in the offering be reduced unless all other securities to be included in such Underwritten
Registration Statement (other than securities to be sold by the Company) are proportionately reduced or entirely excluded from the offering.

 

(b) Company Obligations.

 

(i) The Company
shall advise Holder as expeditiously as possible and within five business days after:

 

(i)        a
Resale Registration Statement, an Underwritten Registration Statement or any amendment thereto has been filed with the Commission and
when such Resale Registration Statement, Underwritten Registration Statement or any post-effective amendment thereto has become effective;

 

(ii)        any
request by the Commission for amendments or supplements to any Resale Registration Statement, Underwritten Registration Statement or the
prospectus included therein or for additional information;

 

(iii)        the
issuance by the Commission of any stop order suspending the effectiveness of any Resale Registration Statement, Underwritten Registration
Statement or the initiation of any proceedings for such purpose;

 

(iv)        the
receipt by the Company of any notification with respect to the suspension of the qualification of the Warrant Shares included therein
for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

(v)         subject
to the provisions in this Agreement, the occurrence of any event that requires the making of any changes in any Resale Registration Statement,
Underwritten Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit
to state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the
light of the circumstances under which they were made) not misleading.

 

Notwithstanding
anything to the contrary set forth herein, when so advising Holder of such events, the Company shall not be obligated, to provide Holder
with any material, nonpublic information regarding the Company, nor shall the Company provide any Holder with any such material, nonpublic
information regarding the Company without Holder’s prior written consent (e-mail being sufficient), in each case other than to the
extent that providing notice to Holder of the occurrence of the events listed in (i) through (v) above constitutes material, nonpublic
information regarding the Company.

 

 

 

    	 	13	 

     

    

 

(ii) The Company
shall use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Resale Registration
Statement or Underwritten Registration Statement as soon as reasonably practicable.

 

(iii) Upon
the occurrence of any Suspension Event, except for such times as the Company is permitted hereunder to suspend, and has suspended, the
use of a prospectus forming part of a Resale Registration Statement or Underwritten Registration Statement as contemplated by this Agreement,
the Company shall use its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such
Resale Registration Statement or Underwritten Registration Statement or a supplement to the related prospectus, or file any other required
document so that, as thereafter delivered to purchasers of the Shares included therein, such prospectus will not include any untrue statement
of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading.

 

(iv) The Company
shall provide the Holder the ability to review disclosure regarding Holder in the Resale Registration Statement or Underwritten Registration
Statement prior to the filing or submission of such Resale Registration Statement or Underwritten Registration Statement and consider
in good faith any reasonable comments of Holder.

 

(v) The Company
shall otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holder,
consistent with the terms of this Agreement, in connection with the registration of the Warrant Shares.

 

(d) Indemnification.

 

(i) Indemnification
by the Company. The Company agrees to indemnify and hold harmless, to the extent permitted by law, Holder, its directors, and officers,
employees, and agents, and each person who controls Holder (within the meaning of the Securities Act or the Exchange Act) and each Affiliate
of Holder from and against any and all losses, claims, damages, liabilities and expenses (including, without limitation, any reasonable
attorneys’ fees and expenses incurred in connection with defending or investigating any such action or claim) caused by any untrue
or alleged untrue statement of material fact contained in any Resale Registration Statement, prospectus included in any Resale Registration
Statement or preliminary prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact
required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in light of the circumstances
in which they were made) not misleading, except insofar as the same are caused by or contained in any information furnished in writing
to the Company by or on behalf of Holder expressly for use therein.

 

(ii) Indemnification
by Holder. Holder agrees to indemnify and hold harmless the Company, its directors, officers, employees and agents, and each person
who controls the Company (within the meaning of the Securities Act or the Exchange Act) and each Affiliate of the Company against any
losses, claims, damages, liabilities and expenses (including, without limitation, reasonable attorneys’ fees and expenses incurred
in connection with defending or investigating any such action or claim) resulting from any untrue statement of material fact contained
in the Resale Registration Statement, prospectus or preliminary prospectus or any amendment thereof or supplement thereto or any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus,
in the light of the circumstances in which they were made) not misleading, but only to the extent that such untrue statement or omission
is contained in any information or affidavit so furnished in writing by Holder expressly for use therein. In no event shall the liability
of any Holder pursuant to this Section 12(d)(ii), when combined with the amounts paid or payable by Holder pursuant to Section
12(d)(iv) be greater in amount than the dollar amount of the net profit received by Holder upon the sale of the Warrant Shares (e.g.
sale proceeds net of selling expenses minus the aggregate exercise price paid for the Warrant Shares sold in the transaction) after giving
rise to such indemnification obligation.

 

 

 

    	 	14	 

     

    

 

(iii) Indemnification
Procedures. Any Person entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any claim
with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right
to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (B) permit such indemnifying party
to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying
party shall not be subject to any liability for any settlement made by the indemnified party without its consent. An indemnifying party
who elects not to assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties
indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of legal counsel to any indemnified
party a conflict of interest exists between such indemnified party and any other of such indemnified parties with respect to such claim.
No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement
which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms
of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
indemnified party of a release from all liability in respect to such claim or litigation.

 

(iv) Contribution.
If the indemnification provided under this Section 12 from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party,
in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of
such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information
supplied by or on behalf of, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s
relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party
as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth above,
any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
pursuant to this Section 12 from any person who was not guilty of such fraudulent misrepresentation. Notwithstanding anything to
the contrary herein, in no event will any party be liable for consequential (including enterprise value, business value or market value
damages), special, exemplary or punitive damages in connection with this Agreement. In no event shall the liability of any Holder pursuant
to this Section 12(d)(iv), when combined with the amounts paid or payable by Holder pursuant to Section 12(d)(ii) be greater
in amount than the net profit received by Holder upon the sale of the Warrant Shares (e.g. sale proceeds net of selling expenses minus
the dollar amount of the aggregate exercise price paid for the Warrant Shares sold in the transaction) giving rise to such indemnification
obligation.

 

(v) Survival.
The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or
on behalf of the indemnified party or any officer, director, employee, agent, Affiliate or controlling person of such indemnified party
and shall survive the transfer of the Warrants or the Warrant Shares purchased pursuant to this Agreement.

 

(e) Expenses of Registration.
All expenses (other than selling expenses) incurred in connection with registrations, filings, or qualifications pursuant to this Section
12, including all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements of counsel
for the Company; and the reasonable fees and disbursements of one counsel for Holder (“Holder Counsel”), shall be borne
and paid by the Company. All selling expenses relating to Warrant Shares registered pursuant to this Section 12 shall be borne
and paid by the Holder.

 

13. No Fractional
Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares
that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole number and the Company
shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional shares.

 

 

 

 

    	 	15	 

     

    

 

14. Notices.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing
and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered
via facsimile or confirmed e-mail at the facsimile number or e-mail address specified below prior to 5:30 P.M., New York City time, on
a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile
or confirmed e-mail at the facsimile number or e-mail address specified below on a day that is not a Trading Day or later than 5:30 P.M.,
New York City time, on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight
courier service specifying next business day delivery, or (iv) upon actual receipt by the Person to whom such notice is required
to be given, if by hand delivery.

 

	 	 	 
	If to the Company:    	 	Esports Technologies, Inc.
	 	 	197 E. California Ave. Ste. 302, Las Vegas, NV 89104
	 	 	Attention: Aaron Speach, President and Chief Executive Officer
	 	 	Email: aspeach@esportstechnologies.com

 

15. Warrant Agent.
The Company shall initially serve as warrant agent under this Warrant. Upon thirty (30) days’ written notice to the Holder, the
Company may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation
resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company
or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant
agent under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant
agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register.

 

16. Miscellaneous.

 

(a) No Rights
as a Stockholder. The Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or
receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant
be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a stockholder
of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification
of stock, consolidation, merger, amalgamation, conveyance or otherwise), receive notice of meetings, receive dividends or subscription
rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the
due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder
to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are
asserted by the Company or by creditors of the Company.

 

(b) Authorized
Shares.

 

(i) Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (a) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (b) take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (c) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be
necessary to enable the Company to perform its obligations under this Warrant.

 

 

 

 

    	 	16	 

     

    

 

(ii) Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.

 

(c) Successors
and Assigns. Subject to the restrictions on transfer set forth in this Warrant and the restrictions on transfer set forth in this
Warrant and compliance with applicable securities laws, this Warrant and the Registration Rights set forth in Section 12 may be
assigned by the Holder. This Warrant may not be assigned by the Company without the written consent of the Holder except to a successor
in the event of a Fundamental Transaction. This Warrant shall be binding on and inure to the benefit of the Company and the Holder and
their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any
Person other than the Company and the Holder any legal or equitable right, remedy or cause of action under this Warrant. This Warrant
may be amended only in writing signed by the Company and the Holder, or their successors and assigns.

 

(d) Amendment
and Waiver. Except as otherwise provided herein, the provisions of the Warrants may be amended and the Company may take any action
herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent
of the Holders of Warrants representing no less than a majority of the Warrant Shares obtainable upon exercise of the Warrants then outstanding.

 

(e) Acceptance.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.

 

(f) Governing
Law; Jurisdiction. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED
BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEVADA WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW
THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING
IN THE STATE OF NEVADA, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY
OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND
AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT.
EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH
SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY)
TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF
PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED
BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.

 

(g) Headings.
The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any
of the provisions hereof.

 

(h) Severability.
In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability
of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby, and the Company and the Holder
will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor,
and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

(i) Nonwaiver and
Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver
of such right or otherwise prejudice the Holder’s rights, powers or remedies. If the Company willfully and knowingly fails to comply
with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts
as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those
of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights,
powers or remedies hereunder.

 

 

 

    	 	17	 

     

    

 

(j) Limitation of
Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any shares of Common Stock or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors
of the Company.

 

(k) Remedies.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.

 

(l) Counterparts.
This Warrant may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic
signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any
counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

(m) Stockholder
Approval. The Company shall provide each shareholder entitled to vote at a special meeting of shareholders of the Company (the
“Shareholder Meeting”), which shall be promptly called and held not later than 120 days after the Closing
(the “Shareholder Meeting Deadline”), a proxy statement soliciting each such shareholder’s
affirmative vote at the Shareholder Meeting for approval of resolutions (“Shareholder Resolutions”)
providing for the approval of the issuance of all of the Warrant Shares in compliance with the rules and regulations of the Trading
Market (without regard to any limitations on conversion or exercise, as applicable, with respect thereto) (the
“Shareholder Approval”, and the date the Shareholder Approval is obtained, the “Shareholder Approval
Date”), and the Company shall use its reasonable best efforts to solicit its shareholders’ approval of such resolutions
and to cause the Board of Directors of the Company to recommend to the shareholders that they approve such resolutions. The Company
shall be obligated to seek to obtain the Shareholder Approval by the Shareholder Meeting Deadline. If, despite the Company’s
reasonable best efforts the Shareholder Approval is not obtained on or prior to the Shareholder Meeting Deadline, the Company shall
cause an additional Stockholder Meeting to be held on or prior to the six month-anniversary of the Closing. If, despite the
Company’s reasonable best efforts the Shareholder Approval is not obtained after such subsequent shareholder meetings, the
Company shall cause an additional Shareholder Meeting to be held each quarter thereafter until such Shareholder Approval is
obtained.

 

[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK]

 

 

 

 

 

 

 

    	 	18	 

     

    

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be duly executed by its authorized officer as of the date first indicated above.

 

	 	 	 	 
	 	ESPORTS TECHNOLOGIES, INC.
	 	 	 
	 	By:	 	                  
	 	Name: 
	 	
    Title:

 

Accepted and Agreed to:

 

CP BF LENDING, LLC

 

By: __________________________

Name:

Title:

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	19	 

     

    

 

SCHEDULE 1

 

FORM OF EXERCISE NOTICE

 

[To be executed by the
Holder to purchase shares of Common Stock under the Warrant]

 

Ladies and Gentlemen:

 

	(1)	The undersigned is the Holder of Warrant No. ___ (the “Warrant”) issued by Esports Technologies, Inc., a Nevada corporation (the “Company”). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the Warrant.

 

	(2)	The undersigned hereby exercises its right to purchase Warrant Shares pursuant to the Warrant.

 

	(3)	The Holder intends that payment of the Exercise Price shall be made as (check one):

 

	 	☐	Cash Exercise

 

	(4)	If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $[●] in immediately available funds to the Company in accordance with the terms of the Warrant.

 

	(5)	Pursuant to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the terms of the Warrant.

 

	(6)	By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder will not beneficially own in excess of the number of shares of Common Stock (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section 11(a), of the Warrant to which this notice relates.

 

	 	 	 
	Dated:	 	
    [●] 202__

	 	 
	Name of	 	 
	Holder:	 	 
	 	 
	By:	 	
    [●]

	Name:	 	
    [●]

	Title:	 	
    [●]

(Signature must conform
in all respects to name of Holder as specified on the face of the Warrant)

 

 

    	 	20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]